Management of steroid sensitive nephrotic syndrome: Revised guidelines

Indian Pediatrics

Volumn 45, Issue 3, 2008, Pages 203-214

  Bagga, Arvind ^a   Afzal, Kamran ^b   Agarwal, Indira ^c   Agarwal, Vinay ^d   Ali, Uma ^e   Bagai, Sanjeev ^f   Banerjee, Sushmita ^g   Gulati, Ashima ^a   Gulati, Sanjeev ^h   Hari, Pankaj ^a   Iyengar, Arpana ⁱ   Jaiswal, O P ^j   Jain, Rupesh ^k   Kanitkar, M ^l   Mantan, Mukta ^m   Mehta, Kamini ⁿ   Mehta, Kumud ^e   Nammalwar, B R ^o   Pahari, Amitava ^p   Patnaik, Saroj K ^q   Phadke, K D ⁱ   Pruthi, P K ^r   Saha, Abhijeet ^s   Sairam, V K ^t   Sengupta, Jayati ^u   Senguttuvan, Prabha ^v   Sethi, Sidharth K ^a   Shah, Mehul ^w   Sharma, Jyoti ^x   Srivastava, R N ^y   Vasudev, A S ^y   Vasudevan, Anil ⁱ   Vijayakumar, M ^z   more..

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b ALIGARH MUSLIM UNIVERSITY   (India)

^c CHRISTIAN MEDICAL COLLEGE   (India)

^d Max Hospital   (India)

^e B J WADIA HOSPITAL FOR CHILDREN   (India)

^f Rockland Hospital   (India)

^g CALCUTTA MEDICAL RESEARCH INSTITUTE   (India)

^h FORTIS HOSPITAL   (India)

ⁱ ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

^j Sunder Lal Jain Hospital   (India)

^k Ekta Institute of Child Health   (India)

^l ARMED FORCES MEDICAL COLLEGE   (India)

^m MAULANA AZAD MEDICAL COLLEGE   (India)

ⁿ LILAVATI HOSPITAL AND RESEARCH CENTRE   (India)

^o KANCHI KAMAKOTI CHILDS TRUST HOSPITAL   (India)

^p Apollo Gleneagles Hospital   (India)

^q Air Force Station   (India)

^r SIR GANGA RAM HOSPITAL   (India)

^s GOVERNMENT MEDICAL COLLEGE AND HOSPITAL   (India)

^t SRI RAMACHANDRA UNIVERSITY   (India)

^u AMRI HOSPITALS   (India)

^v INSTITUTE OF CHILD HEALTH AND HOSPITAL FOR CHILDREN   (India)

^w APOLLO HOSPITAL   (India)

^x Bharati Vidyapeeth's Medical College   (India)

^y INDRAPRASTHA APOLLO HOSPITAL   (India)

^z Mehta Children's Hospital   (India)

more..

Author keywords

Nephrotic syndrome; Practice guidelines; Recommendations

Indexed keywords

ALBUMIN; AMINOTRANSFERASE; BETAMETHASONE; CALCIUM CARBONATE; CORTICOSTEROID; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYCLOSPORIN A; DEFLAZACORT; DEXAMETHASONE; FUROSEMIDE; HYDROCHLOROTHIAZIDE; HYDROCORTISONE; IMMUNOSUPPRESSIVE AGENT; LEVAMISOLE; LOOP DIURETIC AGENT; METHYLPREDNISOLONE; METOLAZONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; POTASSIUM SPARING DIURETIC AGENT; PREDNISOLONE; PREDNISONE; RANITIDINE; SPIRONOLACTONE; STEROID; TACROLIMUS; THIAZIDE DIURETIC AGENT; TRIAMCINOLONE;

ALOPECIA; AMINOTRANSFERASE BLOOD LEVEL; CLINICAL PRACTICE; CONGESTIVE HEART FAILURE; CONTINUOUS INFUSION; CONVULSION; CORTICOSTEROID THERAPY; CREATININE BLOOD LEVEL; DIARRHEA; DIET THERAPY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; EDEMA; FLU LIKE SYNDROME; GASTROINTESTINAL SYMPTOM; GINGIVA HYPERTROPHY; HEADACHE; HEMORRHAGIC CYSTITIS; HIRSUTISM; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERTENSION; HYPOVOLEMIA; KIDNEY BIOPSY; LEUKOPENIA; LIVER TOXICITY; LONG TERM CARE; NAUSEA; NEPHROTIC SYNDROME; NEPHROTOXICITY; NEUROTOXICITY; PATIENT COMPLIANCE; PATIENT REFERRAL; PLASMA VOLUME; PRACTICE GUIDELINE; RASH; RELAPSE; REPRODUCTIVE TOXICITY; RESPIRATORY DISTRESS; REVIEW; SEIZURE; SIDE EFFECT; THROMBOSIS; TREATMENT OUTCOME; VOMITING;

ADJUVANTS, IMMUNOLOGIC; CYCLOPHOSPHAMIDE; GLUCOCORTICOIDS; HUMANS; LEVAMISOLE; MYCOPHENOLIC ACID; NEPHROTIC SYNDROME; NUTRITIONAL STATUS; PREDNISOLONE; PREDNISONE; RECURRENCE; TREATMENT FAILURE;

EID: 41449102048     PISSN: 00196061     EISSN: 00196061     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Consensus Statement on Management of Steroid Sensitive Nephrotic Syndrome. Indian Pediatric Nephrology Group, Indian Academy of Pediatrics. Indian Pediatr 2001; 38: 975-986.
2. Consensus Statement on Management and Audit Potential for Steroid Responsive Nephrotic Syndrome. Report of a Workshop by the British Association for Paediatric Nephrology and Research Unit, Royal College of Physicians. Arch Dis Child 1994; 70: 151-157.
3. Hodson EM, Willis NS, Craig JC. Corticosteroid therapy for nephrotic syndrome in children. Cochrane Database System Rev 2007; CD001533.
4. Primary nephrotic syndrome in children: clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity. A Report of the International Study of Kidney Disease in Children. Kidney Int 1981; 20: 765-771.
5. Hogg R, Portman RJ, Milliner D, Lemley KV, Eddy A, Ingelfinger J. Evaluation and management of proteinuria and nephrotic syndrome in children: Recommendations from a pediatric nephrology panel established at the National Kidney Foundation Conference on proteinuria, albuminuria, risk, assessment, detection and elimination (PARADE). Pediatrics 2000; 106: 1242-1249.
6. Bagga A, Hari P, Srivastava RN. Prolonged versus standard initial prednisolone treatment for idiopathic nephrotic syndrome. Pediatr Nephrol 1999; 13: 824-827.
7. Durkan A, Hodson EM, Willis NS, Craig JC. Non-corticosteroid treatment for nephrotic syndrome in children. Cochrane Database System Rev 2005; CD002290.
8. Bagga A, Sharma A, Srivastava RN. Levamisole therapy in corticosteroid dependent nephrotic syndrome. Pediatr Nephrol 1997; 11: 415-417.
9. Davin JC, Merkus MP. Levamisole in steroid-sensitive nephrotic syndrome of childhood: the lost paradise? Pediatr Nephrol 2005; 20: 10-14.
10. Latta K, von Schnakenburg C, Ehrich JHH. A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children. Pediatr Nephrol 2001; 16: 271-282.
11. Kyrieleis HA, Levtchenko EN, Wetzels JF. Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome. Am J Kidney Dis 2007; 49: 592-597.
12. Cattran DC, Alexopoulos E, Heering P, Hoyer PF, Johnston A, Meyrier A, et al. Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome: Workshop recommendations. Kidney Int 2007; 72: 1429-1447.
13. Westhoff TH, Schmidt S, Zidek W, Beige J, van der Giet M. Tacrolimus in steroid-resistant and steroid-dependent nephrotic syndrome. Clin Nephrol 2006; 65: 393-400.
14. Afzal K, Bagga A, Menon S, Hari P, Jordan SC. Treatment with mycophenolate mofetil and prednisolone for steroid-dependent nephrotic syndrome. Pediatr Nephrol 2007; 22: 2059-2065.
15. Dorresteijn E, Kist-van Holthe J, Levtchenko E, Nauta J, Hop W, Van der Hejden A. Randomized controlled trial of mycophenolate mofetil versus cyclosporine A in children with frequently relapsing nephrotic syndrome. Pediatr Nephrol 2007; 22: 1442 (28 FC)
16. Srivastava RN, Bagga A. Nephrotic syndrome. In: Pediatric Nephrology. 4th edition. New Delhi: Jaypee Brothers; 2005. p. 161-200.
17. Vogt AB, Avner ED. Nephrotic syndrome. In: Nelson Textbook of Pediatrics. 18th edition. Kliegman RM, Behrman RE, Jenson HB, Stanton BF, editors. Philadelphia: WB Saunders; 2007. p 2190-2195.
18. Ruth EM, Kemper MJ, Leumann EP, Laube GF, Neuhaus TJ. Children with steroid-sensitive nephrotic syndrome come of age: long-term outcome. J Pediatr 2005; 147: 202-207.
19. Gulati S, Sharma RK, Gulati K, Singh U, Srivastava A. Longitudinal followup of bone mineral density in children with idiopathic nephrotic syndrome. Nephrol Dial Transpl 2005; 20: 1598-1603.
20. American Academy of Pediatrics. Immunization in special clinical circumstances. In: Pickering LK, Baker CJ, Long SS, McMillan JA. Red Book: 2006 Report of the Committee on Infectious Diseases, 27th edn. Elk Grove Village, IL: American Academy of Pediatrics; 2006. p. 67-104.
21. American Academy of Pediatrics, Committee on Infectious Diseases. Recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine and antibiotic prophylaxis. Pediatrics 2000; 106: 362-366.
22. Shah RC, Shah NK, Kukreja S. Pneumococcal vaccines. In: Shah RC, Shah NK, Kukreja S, editors. IAP Guide Book on Immunization. Mumbai: 2007. p. 35-36.
23. American Academy of Pediatrics. Varicella-zoster infections. In: Pickering LK, Baker CJ, Long SS, McMillan JA. Red Book: 2006 Report of the Committee on Infectious Diseases, 27th edn. Elk Grove Village, IL: American Academy of Pediatrics; 2006. p. 711-725.
24. Chauhan LS, Arora VK. Management of pediatric tuberculosis under the Revised National Tuberculosis Control Program (RNTCP). Indian Pediatr 2004; 41: 901-905.
25. Indian Pediatric Nephrology Group. Evaluation and management of hypertension. Indian Pediatr 2007; 44: 103-121.
26. Axelrod L. Glucocorticoid therapy. In: Endocrinology. 5th edition. DeGroot LJ, Jameson JL. Philadelphia: Elsevier Saunders; 2006. p. 2329-2342.